COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,552 Articles (22,400 medRxiv, 8,152 bioRxiv)

Most recent first Previous |  Page 788: Articles 7871-7880  | Next

Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Pitzer, V. E., Patalon, T.
10.1101/2022.03.24.22272835 — Posted: 2022-03-24
Risk factors for SARS-CoV-2 transmission in student residences: a case-ascertained study in Leuven, Belgium from October 2020 until May 2021
Vanbesien, M., Molenberghs, G., Geenen, C., Thibaut, J., Gorissen, S., Andre, E., raymenants, J.
10.1101/2022.03.23.22272836 — Posted: 2022-03-24
COVID-19 Vaccine Effectiveness against the Omicron BA.2 variant in England
Kirsebom, F., Andrews, N., Stowe, J., Toffa, S., Sachdeva, R., Gallagher, E., Groves, N., O'Connell, A.-M., Chand, M., Ramsay, M., Lopez Bernal, J.
10.1101/2022.03.22.22272691 — Posted: 2022-03-24
Inverse proportionality between height and duration of epidemic peaks not observed for the COVID-19 epidemic in Japan
Tomie, T.
10.1101/2022.03.23.22272840 — Posted: 2022-03-24
Accuracy of COVID-19 self-tests with unsupervised nasal or nasal plus oropharyngeal self-sampling in symptomatic individuals in the Omicron period
Schuit, E., Venekamp, R. P., Hooft, L., Veldhuijzen, I. K., van den Bijllaardt, W., Pas, S. D., Zwart, V. F., Lodder, E. B., Hellwich, M., Koppelman, M., Molenkamp, R., Wijers, C., Vroom, I. H., Smeets, L. C., Nagel-Imming, C. R., Han, W. G., van den Hof, S., Kluytmans, J. A., van de Wijgert, J. H., Moons, K. G.
10.1101/2022.03.24.22272891 — Posted: 2022-03-24
Prognostic factors for mortality, ICU and hospital admission due to SARS-CoV-2: A systematic review and meta-analysis of cohort studies in Europe
Vardavas, C., Mathioudakis, A. G., Nikitara, K., Stamatelopoulos, K., Georgiopoulos, G., Phalkey, R., Leonardi-Bee, J., Fernandez, E., Carnicer-Pont, D., Vestbo, J., Semenza, J. C., Deogan, C., Suk, J. E., Kramarz, P., Lamp, F., Penttinen, P.
10.1101/2022.03.24.22272870 — Posted: 2022-03-24
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
Schloer, A., Hirschberg, S., Ben Amor, G., Meister, T. L., Arora, P., Pöhlmann, S., Hoffmann, M., Pfaender, S., Kamal Eddin, O., Kamhieh-Milz, J., Hanack, K.
10.1101/2022.03.24.485614 — Posted: 2022-03-24
Differences in neuroinflammation in the olfactory bulb between D614G, Delta and Omicron BA.1 SARS-CoV-2 variants in the hamster model
Bauer, L., Rissmann, M., Benavides, F., Leijten, L., Begeman, L., Veldhuis Kroeze, E., van Run, P., Koopmans, M. P. G., Rockx, B., van Riel, D.
10.1101/2022.03.24.485596 — Posted: 2022-03-24
Influenza infection in ferrets with SARS-CoV-2 infection history
de Melo, C. V. B., Peters, F., van Dijken, H., Lenz, S., van de Ven, K., Wijsman, L., Gommersbach, A., Schouten, T., van Kasteren, P. B., van den Brand, J. M. A., de Jonge, J.
10.1101/2022.03.22.485425 — Posted: 2022-03-24
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
Gonzalez-Dominguez, I., Martinez, J. L., Slamanig, S., Lemus, N., Liu, Y., Lai, T. Y., Carreno, J. M., Singh, G., Singh, G., Schotsaert, M., Mena, I., McCroskery, S., Coughlan, L., Krammer, F., Garcia-Sastre, A., Palese, P., Sun, W.
10.1101/2022.03.21.485247 — Posted: 2022-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).